In this Issue:
TMAO enhances platelet hyperreactivity and thrombosis risk
IV-TXA for reducing bleeding and transfusions in THA
Outcomes after VCF use in noncancer patients with acute venous thromboembolism
Dynamic risk stratification of patient long-term outcome after PEA
Altered fibrin clot properties are associated with increased risk of PTS
Impact of corticosteroids on haemostasis in healthy subjects
A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin
AD peptide Aβ promotes thrombin generation through activation of coagulation factor XII
Prevalence of DVT and PE in patients with SVT
Clinical variability in a cohort of patients diagnosed with type 1 VWD in the US
Please login below to download this issue (PDF)